首页 › 多发性骨髓瘤 › 密苏里州 › Kansas City
Kansas City MO 多发性骨髓瘤临床试验
10项针对 多发性骨髓瘤的研究正在 Kansas City及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
招募中1 期
- University of Kansas Hospital-Westwood Cancer Center, Westwood · 距离 5 英里
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
招募中4 期
- Kansas University Medical Center, Westwood · 距离 5 英里
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
招募中3 期
- MidAmerica Cancer Care, Kansas City
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
招募中2 期
- The University of Kansas Cancer Center - Westwood, Westwood · 距离 5 英里
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
招募中3 期
- University of Kansas, Westwood · 距离 5 英里
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
招募中3 期
- Kansas City VA Medical Center, Kansas City
- American Oncology Partners, P.A. Dba MidAmerica Cancer Care, Kansas City
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
招募中3 期
- Kansas City Veterans Affairs Medical Center, Kansas City
Integrated Cancer Repository for Cancer Research
招募中观察性研究欢迎健康志愿者
- Saint Luke's Cancer Institute, East, Kansas City
- Saint Luke's Cancer Institute, Kansas City
- Saint Luke's Cancer Institute, Kansas City North, Kansas City
- 以及另外 1 项
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
招募中3 期
- Research Medical Center, Kansas City
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
招募中1 期
- University of Kansas Clinical Research Center, Westwood · 距离 5 英里
其他城市的 多发性骨髓瘤试验
- New York City, NY60 项研究
- Atlanta, GA42 项研究
- Boston, MA42 项研究
- Houston, TX38 项研究
- Durham, NC37 项研究
- Nashville, TN32 项研究
- Denver, CO27 项研究
- Rochester, MN24 项研究
- St. Louis, MO24 项研究
- Columbus, OH24 项研究
- Baldwin Park, CA23 项研究
- Edison, NJ22 项研究
Kansas City的其他研究
- 乳腺癌34 项研究
- 非小细胞肺癌31 项研究
- 心力衰竭25 项研究
- 癌症（所有类型）21 项研究
- 肺癌19 项研究
- 结直肠癌16 项研究
- 转移性癌症15 项研究
- 急性髓系白血病15 项研究
- 前列腺癌14 项研究
- 卵巢癌11 项研究
- 肥胖症11 项研究
- 2型糖尿病11 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。